Title: Bye-Bye China?

Instead of closing its doors on China, Western pharma industry needs to take a balanced approach and perform proper due diligence based on objective criteria.

Click Here For Complete Article Text

 

   Person Information
   Application Sequencing
 325412 - Pharmaceutical Preparation Manufacturing                
 541711 - Research and Development in Biotechnology                
Company  Product  Process  Other  Subjects  Event  Event  Date  Location  Publication  Publication  Date Text  Descriptor
  • Quality Assurance

 

 

 

  • China

 

  • Contract Pharma

 

  • 11/17/2020

 

  • Article